Profile data is unavailable for this security.
About the company
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The principal activities of the Company are the manufacture, development and distribution of medical diagnostics products for the food sensitivity testing market. The Company’s segments include Health and Nutrition, and Corporate. The Health and Nutrition division specializes in the research, development and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis for the general public, clinics and health professionals as well as supplying the point-of-care Food Detective test. Its range of food sensitivity and functional health tests can help identify the root cause of gut health issues. Its brands include FoodPrint, Food Detective, CNSLab, and My Health Tracker. The Company has a global customer base across more than 63 countries, and its products are used by more than 170 laboratories worldwide.
- Revenue in GBP (TTM)8.06m
- Net income in GBP1.37m
- Incorporated2004
- Employees84.00
- LocationCambridge Nutritional Sciences PLCEden Research ParkHenry Crabb Road, LittleportCAMBRIDGE CB6 1SEUnited KingdomGBR
- Phone+44 135 386 2220
- Fax+44 125 976 1853
- Websitehttps://www.cnsplc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Image Scan Holdings Plc | 1.62m | -288.02k | 1.98m | 13.00 | -- | 1.39 | -- | 1.23 | -0.0021 | -0.0021 | 0.0118 | 0.0105 | 0.6459 | 1.75 | 2.43 | -- | -11.50 | 0.0905 | -17.47 | 0.1358 | 58.50 | 52.65 | -17.80 | 0.0917 | 1.85 | -- | 0.0616 | 0.00 | -43.45 | -14.23 | -239.13 | -- | 34.92 | -- |
| Genincode PLC | 2.91m | -4.97m | 3.16m | 36.00 | -- | 1.19 | -- | 1.08 | -0.0232 | -0.0232 | 0.0137 | 0.0093 | 0.6562 | 15.74 | 2.87 | 80,944.45 | -111.87 | -- | -164.53 | -- | 53.02 | -- | -170.49 | -- | 2.73 | -10.96 | 0.0669 | -- | 25.05 | -- | 36.80 | -- | -- | -- |
| Surgical Innovations Group Plc | 11.92m | -1.44m | 4.20m | 88.00 | -- | 0.4903 | -- | 0.3523 | -0.0015 | -0.0015 | 0.0128 | 0.0092 | 0.9314 | 2.91 | 4.72 | 135,397.70 | -11.22 | -7.76 | -14.17 | -9.60 | 27.89 | 29.97 | -12.04 | -11.66 | 0.9524 | 8.46 | 0.0987 | -- | -0.5743 | 2.16 | -281.73 | -- | -8.28 | -- |
| Cambridge Nutritional Sciences PLC | 8.06m | 1.37m | 4.76m | 84.00 | 3.50 | 0.4305 | 2.38 | 0.5905 | 0.0057 | 0.0057 | 0.0338 | 0.0465 | 0.6153 | 3.59 | 3.57 | 95,940.48 | 10.42 | -3.22 | 11.69 | -3.67 | 66.44 | 58.85 | 16.94 | -7.21 | 3.79 | -- | 0.021 | -- | -14.77 | -3.23 | 577.44 | -- | -29.24 | -- |
| Feedback plc | 885.62k | -7.32m | 4.89m | 28.00 | -- | 0.7925 | -- | 5.52 | -0.2618 | -0.2618 | 0.0309 | 0.1407 | 0.1174 | -- | 9.83 | 31,629.29 | -96.97 | -38.54 | -105.98 | -41.65 | 87.92 | 90.05 | -826.25 | -435.27 | -- | -- | 0.00 | -- | -25.05 | 14.50 | -121.85 | -- | -1.14 | -- |
| Proteome Sciences plc | 4.53m | -3.33m | 6.23m | 36.00 | -- | -- | -- | 1.38 | -0.0113 | -0.0113 | 0.0153 | -0.0291 | 0.5087 | 5.92 | 5.75 | 125,750.00 | -37.44 | -8.02 | -- | -- | 17.43 | 45.80 | -73.60 | -15.07 | 0.0774 | -2.51 | 2.26 | -- | -2.80 | 0.9731 | -39.42 | -- | 31.03 | -- |
| Rua Life Sciences PLC | 5.17m | -850.00k | 8.38m | 33.00 | -- | 1.17 | -- | 1.62 | -0.0137 | -0.0137 | 0.0832 | 0.1151 | 0.5459 | 1.18 | 6.23 | -- | -9.18 | -- | -10.42 | -- | 77.10 | -- | -16.82 | -- | 3.87 | -- | 0.0995 | -- | -- | -- | -- | -- | -- | -- |
| Verici DX PLC | 1.40m | -5.58m | 10.44m | 15.00 | -- | 0.9197 | -- | 7.45 | -0.023 | -0.023 | 0.0058 | 0.0075 | 0.2298 | -- | 1.67 | 77,916.49 | -91.48 | -- | -119.40 | -- | 81.60 | -- | -398.12 | -- | -- | -- | 0.102 | -- | 229.62 | -- | 32.75 | -- | -- | -- |
| Genedrive PLC | 954.00k | -5.23m | 11.33m | 43.00 | -- | 4.78 | -- | 11.87 | -0.0093 | -0.0093 | 0.0017 | 0.0023 | 0.1984 | -- | 1.80 | 22,186.05 | -108.81 | -77.52 | -153.92 | -106.30 | -- | -- | -548.32 | -1,016.12 | 1.64 | -- | 0.00 | -- | 90.42 | -2.07 | 26.06 | -- | -10.48 | -- |
| Cellbxhealth PLC | 2.62m | -15.78m | 11.96m | 119.00 | -- | 0.2897 | -- | 4.56 | -0.0489 | -0.0489 | 0.0081 | 0.0362 | 0.1028 | 0.5939 | 1.46 | 22,050.42 | -61.80 | -41.90 | -72.78 | -46.81 | 62.27 | 18.55 | -601.37 | -1,051.13 | 2.63 | -470.57 | 0.2387 | -- | 30.92 | -- | 29.34 | -- | -- | -- |
| Abingdon Health PLC | 8.43m | -3.42m | 15.06m | 121.00 | -- | 2.19 | -- | 1.79 | -0.0176 | -0.0176 | 0.0435 | 0.0274 | 1.17 | 9.71 | 3.87 | 69,661.16 | -47.42 | -54.04 | -70.70 | -85.91 | 44.32 | 30.37 | -40.51 | -110.07 | 1.58 | -- | 0.1625 | -- | 37.39 | 9.99 | -168.69 | -- | -26.92 | -- |
| Inspiration Healthcare Group PLC | 45.20m | -11.44m | 15.47m | 214.00 | -- | 0.9449 | -- | 0.3422 | -0.1275 | -0.1275 | 0.5038 | 0.1826 | 1.03 | 2.00 | 5.91 | 211,215.00 | -25.96 | -6.05 | -33.03 | -7.45 | 44.39 | 46.62 | -25.32 | -7.01 | 1.11 | 2.42 | 0.441 | -- | 1.65 | 16.56 | -148.04 | -- | 39.05 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Barclays Bank Plc (Private Banking)as of 30 Jun 2025 | 8.08m | 3.40% |
| Unicorn Asset Management Ltd.as of 31 Jan 2026 | 3.70m | 1.56% |
| Octopus Investments Ltd.as of 31 May 2025 | 0.00 | 0.00% |
